MENLO PARK, Calif.–IncellDx, Inc. today announced a supply agreement with Accuri Cytometers, Inc. that combines new patented technology from IncellDx with the unique capabilities available from the Accuri C6 Flow Cytometer® technology.

“The robust, bench-top flow cytometer system has demonstrated excellent performance when combined with reagents from the HPV OncoTectTM E6, E7 mRNA Kit”

The HPV OncoTect™ E6, E7 mRNA test provides quantification of the overexpression of E6/E7 mRNA in each cell, as well as the total proportion of cells that are overexpressing. This information has promise of providing a more specific indication on whether an HPV infection is transforming into cervical cancer.

“The robust, bench-top flow cytometer system has demonstrated excellent performance when combined with reagents from the HPV OncoTectTM E6, E7 mRNA Kit,” said Dr. Bruce Patterson, CEO of IncellDx, Inc. “With this agreement IncellDx will have an automated, complete solution for cervical cancer screening with the potential to be widely disseminated in the global market.”

The HPV OncoTect test can be performed directly on routine liquid-based cytology samples and provides results in about 3.5 hours. An automation upgrade is also available that allows 96 samples to be performed in just two hours. The HPV OncoTect test is CE marked and is available in Europe, South America, and Southeast Asia. Neither the Accuri C6 flow cytometer nor the IncellDx HPV OncoTect E6, E7 mRNA Kit has been cleared by the Food and Drug Administration for marketing in the United States.

The C6 flow cytometer also performs additional tests from the IncellDx product line, including the HIVTROPISM Probe and the HCVVR Viral Reservoirs Probe. These probes are currently available as Research Use Only (RUO) products and are being used in Phase II-III clinical trials of new therapeutics to determine patient response.

About IncellDx

IncellDx is a privately held company located in Menlo Park, California. IncellDx is a molecular diagnostics company dedicated to the detection and monitoring of life threatening viral diseases such as cervical cancer, HIV/AIDS, hepatitis and organ transplant rejection.

About Accuri Cytometers

Accuri Cytometers, Inc. is a life sciences company developing and marketing revolutionary high performance cell analysis systems designed to bring the power of flow cytometry into the labs of life science researchers everywhere. The Accuri CSampler® adds simple, reliable and user-friendly automation to the Accuri C6 Flow Cytometer System. For more information, please visit www.AccuriCytometers.com.